Board of Directors

Bruce Shenitz
Mr. Shenitz is a writer, editor, and information professional living in New York. He was formerly the deputy editor of Out magazine, and before that, a reporter at Newsweek for more than 10 years. Mr. Shenitz holds degrees from Yale University. His partner of 20 years–and husband of one year–died of leukemia in February 2011.

Vincent Santillo, MD
Dr. Vincent Santillo is an internist in New York, New York and is affiliated with Bellevue Hospital Center. He received his medical degree from Columbia University College of Physicians & Surgeons Dr. Santillo has written several peer reviewed articles and book chapters on Prostate Cancer treatment. He earned a MBA from Columbia University and a BS in Economics from the University of Pennsylvania, Wharton School of Business. Dr Santillo was diagnosed and treated for prostate cancer at age 33.

Keith Shepard
Mr. Sheppard is a internationally respected electric power generation consultant. Mr. Sheppard was diagnosed with locally advanced prostate cancer in 2009 and is widely known as a national prostate cancer advocate. Mr. Shepard holds engineering degrees from University of Missouri and Carnegie-Mellon University.

Board of Advisors

Thomas O. Blank, PhD
Department of Human Development and Family Studies, University of Connecticut
Dr, Blank is a social psychologist, focusing on  the psychosocial of cancer, aging, masculinity and GLBT health issues.  Dr. Blank has also written about his own journey as a prostate cancer survivor. Dr. Blank earned  his Ph. D. in Psychology from Columbia University.

Joel Conarroe
President Emeritus, John Simon Guggenheim Foundation, former president, PEN American Center, former dean, University of Pennsylvania and one of America’s leading philanthropists and literary scholars.

Phil Golz
Phil Golz is an entrepreneur and healthcare innovation specialist who has worked in healthcare roles for almost 20 years in the United States, Europe and Latin America.  He held a number of roles within the Pharmaceutical industry (Janssen, GlaxoSmithKline and ViiV Healthcare) where he specialized in leading technology and innovation groups and more recently led the commercial development of HealthUnlocked, the worlds leading Social Network for health, as well as launching and leading their US office. Today, he advises healthcare non-profits and technology companies in the US and Europe, with a mission to improve patient care and outcomes through technology and innovation.

David Latini, PhD
Dr. Latini is a clinical health psychologist, focusing on cancer survivorship and symptom management for persons living with genitourinary cancer. He completed his PhD in educational psychology at Stanford University and then completed a respecialization diploma in clinical psychology at California School of Professional Psychology. He written about  psycho-social aspects of men diagnosed with prostate cancer and has recently published research regarding quality of life issues for gay men diagnosed with prostate cancer.

Franklyn Lowe, M.D., M.P.H.
Associate Director, Department of Urology, St. Luke’s-Roosevelt Medical Center, New York
Dr. Lowe was previously Chairman of the American Urological Association (AUA) Complementary and Alternative Medicine Committee (2001-2009) as well as a member of the Benign Prostatic Hyperplasia (BPH) Guidelines Committee (1996-2003) and By-Laws Committee (1993-2001). He is currently on the Expert Panel of the Communications Committee of the AUA. Dr. Lowe is also a member of the New York Section of the AUA (executive board member), New York Academy of Medicine (former President of the Section on Urology), New York State Urological Association, American Association of Clinical Urologists, and the Société Internationale d’Urologie.

Daniel Shasha, M.D
Attending, Department of Radiation Oncology, Beth Israel Medical Center, New York
Dr. Shasha is an expert in cancers of the male genitourinary tract, with a specific focus on treatment of prostate cancer. He has extensive experience using 3-dimensional conformal radiotherapy, permanent radioactive seed implants and temporary high dose rate implants of the prostate. Dr. Shasha is leader of the Beth Israel Comprehensive Prostate Cancer Program, which allows men to discuss their treatment options in a dual consultation with a radiation oncologist and a urologic oncologist simultaneously.

Joseph Wagner, M.D.
Director, Robotic Surgery Program, Hartford Hospital, Connecticut
Dr. Wagner is a pioneer in robotic surgery, performing some of the first cases in 2001. He performs minimally invasive surgery for virtually all urologic cancers. He was the physician in charge of urologic oncology at Beth Israel Medical Center, NY, NY from 1997-2003. Dr. Wagner joined the Hartford Hospital Medical Staff in 2003 and performed the first robotic surgery in CT in December of that year.


Malecare is a highly professional, nonhierarchical and lean organization, which values diversity and commitment to the issues and results. Malecare is looking for licensed social workers and psychologists with strong clinical skills, an open mindset, and proven applied intelligence. C.V. and letter may be sent via e-mail to .